Skip Navigation


JAC Advance Access originally published online on June 23, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
54/2/542    most recent
dkh339v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Drago, L.
Right arrow Articles by Gismondo, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drago, L.
Right arrow Articles by Gismondo, M. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy 2004 54(2):542-545; doi:10.1093/jac/dkh339
JAC vol.54 no.2 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.

Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides

Lorenzo Drago*, Elena De Vecchi, Lucia Nicola, Alberto Colombo and Maria Rita Gismondo

Laboratory of Clinical Microbiology, Department of Clinical Sciences ‘L. Sacco’ Teaching Hospital, University of Milan, Via GB Grassi 74, 20157 Milan, Italy

* Corresponding author. Tel: +39-0239042469; Fax: +39-0250319651; Email: microbio{at}unimi.it

Objective: The in vitro abilities of telithromycin, azithromycin and clarithromycin to select for resistance were compared by testing isolates of Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae and ß-haemolytic streptococci.

Methods: Five strains each of ß-lactamase-positive and ß-lactamase-negative H. influenzae, ß-lactamase-positive and ß-lactamase-negative M. catarrhalis, S. pneumoniae, ß-haemolytic group A, group C and group G streptococci and three strains of ß-lactamase-negative ampicillin-resistant H. influenzae were evaluated. Development of resistance was determined by multi-step and single-step methodologies. For multi-step studies, MIC values were determined after five serial passages on antibiotic-gradient plates and after 10 serial passages on antibiotic-free plates. Acquisition of resistance was defined as an increase of ≥4-fold from the starting MIC. In single-step studies, the rate of spontaneous mutations was calculated after a passage on plates containing antibiotics at concentrations equal to the highest NCCLS breakpoints.

Results: Azithromycin, clarithromycin and telithromycin gave a ≥4-fold increase in 20, 20 and 10 streptococcus strains, in 4, 5 and 0 H. influenzae strains and in 2, 7 and 4 M. catarrhalis strains, respectively. After 10 passages on antibiotic-free plates, 21/26 strains for azithromycin, 22/32 for clarithromycin and 1/14 for telithromycin maintained high MIC values. In single-step studies, the frequency of mutations was <10–10 for H. influenzae and M. catarrhalis for telithromycin, azithromycin and clarithromycin. Telithromycin induced mutations at a lower rate than azithromycin and clarithromycin in streptococcal strains.

Conclusion: Telithromycin showed a very limited ability to select for resistance in respiratory pathogens compared with azithromycin and clarithromycin.

Keywords: azithromycin , clarithromycin , ketolides , in vitro selection of resistance , respiratory pathogens


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
K. Watanabe, K. Murakami, R. Sato, K. Kashimura, M. Miura, S. Ootsu, H. Miyajima, M. Nasu, T. Okimoto, M. Kodama, et al.
Effect of Sucralfate on Antibiotic Therapy for Helicobacter pylori Infection in Mice
Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4582 - 4588.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.